Published on
February 10, 2023
- 19:33 GMT
Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl ...
Summary Company Announcement Date: October 02, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Presence of Glass Particulates Company Name: Hospira, Inc. Brand Name: Product …
Distribution channels:
Consumer Goods
